Nessun risultato.
EU Union Register of Medicinal Products (12)
EU/3/26/3277 (Active substance: Asedebart) - Orphan designation - Commission Decision (2026) 5999 of Thu, 20 Aug 2026 - European Medicines Agency (EMA) procedure number: EMA/OD/0000332804
Apri →EU/3/26/3286 (Active substance: Humanised IgG4 monoclonal antibody against activated protein C) - Orphan designation - Commission Decision (2026) 6008 of Thu, 20 Aug 2026 - European Medicines Agency (EMA) procedure number: EMA/OD/0000349775
Apri →EU/3/26/3275 (Active substance: Insulin, human) - Orphan designation - Commission Decision (2026) 5997 of Thu, 20 Aug 2026 - European Medicines Agency (EMA) procedure number: EMA/OD/0000307462
Apri →EU/3/25/3076 (Active substance: 4-Amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(hydroxymethyl)pyrimidin-2-one) - Transfer of orphan designation - Commission Decision (2026) 5988 of Thu, 20 Aug 2026 - European Medicines Agency (EMA) procedure number: EMA/OD/0000319314
Apri →EU/3/26/3285 (Active substance: Zolacabtagene autoleucel) - Orphan designation - Commission Decision (2026) 6007 of Thu, 20 Aug 2026 - European Medicines Agency (EMA) procedure number: EMA/OD/0000348467
Apri →Pombiliti (Active substance: cipaglucosidase alfa) - Centralised - Yearly update - Commission Decision (2026) 5989 of Thu, 20 Aug 2026
Apri →EU/3/26/3283 (Active substance: RNA, (Um-sp-(2′-deoxy-2′-fluoro)A-sp-Gm-Am-Am-(2′-deoxy-2′-fluoro)A-Cm-Um-Cm-Am-Um-Am-Gm-(2′-deoxy-2′-fluoro)C-Gm-(2′-deoxy-2′-fluoro)A-Um-Um-Gm-Cm-Am-sp-Cm-sp-Am), complex with RNA (Um-sp-Gm-sp-Cm-Am-Am-Um-(2′-deoxy-2′-fluoro)C-Gm-(2′-deoxy-2′-fluoro)C-(2′-deoxy-2′-fluoro)U-(2′-deoxy-2′-fluoro)A-Um-Gm-Am-Gm-Um-Um-Um-Cm-Um-Am)…
Apri →EU/3/26/3281 (Active substance: Bimiralisib) - Orphan designation - Commission Decision (2026) 6003 of Thu, 20 Aug 2026 - European Medicines Agency (EMA) procedure number: EMA/OD/0000338542
Apri →EU/3/26/3280 (Active substance: Imsidolimab) - Orphan designation - Commission Decision (2026) 6002 of Thu, 20 Aug 2026 - European Medicines Agency (EMA) procedure number: EMA/OD/0000335063
Apri →EU/3/26/3279 (Active substance: Small interfering RNA against the human PLN gene, conjugated to a bicyclic peptide, sodium salt) - Orphan designation - Commission Decision (2026) 6001 of Thu, 20 Aug 2026 - European Medicines Agency (EMA) procedure number: EMA/OD/0000334779
Apri →EU/3/26/3278 (Active substance: 4-(4-Bromo-2-oxo-3H-benzimidazol-1-yl)-N-(4-iodophenyl)piperidine-1-carboxamide) - Orphan designation - Commission Decision (2026) 6000 of Thu, 20 Aug 2026 - European Medicines Agency (EMA) procedure number: EMA/OD/0000333976
Apri →EU/3/26/3276 (Active substance: Paltusotine) - Orphan designation - Commission Decision (2026) 5998 of Thu, 20 Aug 2026 - European Medicines Agency (EMA) procedure number: EMA/OD/0000323219
Apri →